{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:27:10Z","timestamp":1789460830692,"version":"build-2803163510"},"reference-count":16,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,6,28]],"date-time":"2009-06-28T00:00:00Z","timestamp":1246147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objectives\u2002<\/jats:bold>To assess the cost\u2010effectiveness of current monotherapies and prospective combinations for treating visceral leishmaniasis (VL) in Bihar, India in terms of years of life lost (YLL) averted as well as deaths averted.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold>We employed two methods to estimate the number of avertable deaths in our analysis: one using estimated mortality, the other using direct incidence estimates for VL. Costs of care are based on an average private hospital in Bihar, and data on drug costs were obtained both locally and from the World Health Organization.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>The cost of monotherapies per averted YLL ranged from US$2 for paromomycin in an outpatient setting to US$20\u201322 for AmBisome<jats:sup>\u00ae<\/jats:sup>at 20\u2003mg\/kg. The corresponding costs per death averted ranged from US$53\u201354 to US$523\u2013527. Combinations ranged US$5\u20138 per YLL averted and US$124\u2013213 per death averted.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold>The available treatments for VL are cost\u2010effective, and our mortality and incidence\u2010based methods produce consistent estimates. The combinations considered here were more cost\u2010effective than most monotherapies. Having multiple treatment options and combining drugs are also likely to reduce drug pressure and prolong the drugs\u2019 life\u2010span of effective use.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2009.02306.x","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T01:25:59Z","timestamp":1246238759000},"page":"918-925","source":"Crossref","is-referenced-by-count":43,"title":["Cost\u2010effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India"],"prefix":"10.1111","volume":"14","author":[{"given":"Piero","family":"Olliaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Darley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanan","family":"Laxminarayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(05)61006-8"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/519690"},{"key":"e_1_2_7_4_1","first-page":"62","article-title":"Epidemiology of visceral leishmaniasis in India","volume":"12","author":"Bora D","year":"1999","journal-title":"National Medical Journal of India"},{"key":"e_1_2_7_5_1","first-page":"451","volume-title":"Disease Control Priorities in Developing Countries","author":"Cattand P","year":"2006"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost\u2010Effectiveness in Health and Medicine","author":"Gold MR","year":"1996"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2006.01732.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2008.02195.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70296-6"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.73-79.2006"},{"key":"e_1_2_7_11_1","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management","volume":"3","author":"Sundar S","year":"2007","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/318121"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/591972"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2006.01782.x"},{"key":"e_1_2_7_15_1","volume-title":"Elimination of Kala\u2010Azar From Endemic Countries in the South\u2010East Asia Region. Health Ministers\u2019 Sign Memorandum of Understanding","author":"WHO","year":"2005"},{"key":"e_1_2_7_16_1","volume-title":"Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis","author":"WHO","year":"2007"},{"key":"e_1_2_7_17_1","volume-title":"WHO\/SEARO. Kala Azar: Why Kala Azar Elimination is Possible in South Asia Countries?","author":"WHO","year":"2008"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2009.02306.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2009.02306.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T22:44:03Z","timestamp":1710456243000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2009.02306.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1365-3156.2009.02306.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2009.02306.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}